1 |
Park S, Ahn IS, Kim DS, Kang S, Kwon DY, Yang HJ. Anti-obesity Effects of Tae-Um-Jo-Wee-Tang and Do-Dam-Tang in Female Rats with Diet-induced Obesity. J Appl Biol Chem 2010;53(1):44-50.
DOI
|
2 |
Kim KS, Lee DU, Kim YL, Hwang MJ, Kim GW, Koo BS. Anti-obesity and Anti-hyperlipidemic Effects of Taeyeumjowee-tang and its modified prescription. J of Oriental Neuropsychiatry 2007;18(2):57-74.
|
3 |
Hsiao MH, Ko SG, Jun CY, Park JH, Choi YK. Effects of Taeumjowe-tang-gagambang on the Glycometabolism and Lipidmetabolism in the Liver Tissue of Diet-induced Obesity Mice. Korean J Oriental Physiology & Pathology 2010;24(4):638-45.
|
4 |
Yokoi H, Mizukami H, Nagatsu A, Ohno T, Tanabe H, Inoue M. Peroxisome Proliferator-Activated Receptor g Ligands Isolated from Adlay Seed (Coix lacryma-jobi L. var. ma-yuen STAPF.). Biol Pharm Bull 2009;32(4):735-40.
DOI
|
5 |
Song MY, Jung HW, Park YK. Antiobesity Effect of Water Extract of Coix lacrymajobi var. mayuen in High Fat Fed C5BL/6 Mice. J Korean Med Obes Res 2016;16(1):27-35.
DOI
|
6 |
Bhangu A, Soreide K, Di Saverio S, Assarsson JH, Drake FT. Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management. Lancet 2015 Sep 26;386(10000):1278-87.
DOI
|
7 |
Yu CW, Juan LI, Wu MH, Shen CJ, Wu JY, Lee CC. Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis. Br J Surg 2013 Feb;100(3):322-9.
DOI
|
8 |
Han BH, Yoon JJ, Kim HY, Ahn YM, Hong MH, Son CO, et al. Inhibitory Effects of Ojeoksan on TNF- -induced Vascular Inflammation in Human Umbilical Vein Endothelial Cells. Kor J Herbol 2018;33(4):59-67.
DOI
|
9 |
Choi HM, Moon SO, Lee HH, Lee HD. Inhibitory effect of by Ojeok-san lipid accumulation in high fat diet-induced obesity mice and 3T3-L1 adipocytes. Kor J Herbol 2015;30(4):121-8.
DOI
|
10 |
Xiao YL. Me J. Wujisan treatment for chronic pelvic inflammatory disease in 80 cases. Jilin Journal of Traditional Chinese Medicine 2002 Jan;22(1):27.
|
11 |
Jeong JS, Kwon HS. Prevalence and Clinical Characteristics of Dyslipidemia in Koreans. Endocrinol Metab (Seoul) 2017 Mar;32(1):30-5.
DOI
|
12 |
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285(19):2486-97.
DOI
|
13 |
Klempfner R, Erez A, Sagit BZ, Goldenberg I, Fisman E, Kopel E, et al. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry. Circ Cardiovasc Qual Outcomes 2016;9(2):100-8.
DOI
|
14 |
Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, et al.; European Atherosclerosis Society Consensus Panel. Triglyceriderich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011 Jun;32(11):1345-61.
DOI
|
15 |
Goldberg IJ, Eckel RH, McPherson R. Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol 2011 Aug;31(8):1716-25.
DOI
|
16 |
Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report. J Clin Lipidol 2015 Mar-Apr;9(2):129-69.
DOI
|
17 |
Guo M, Liu Y, Gao ZY, Shi DZ. Chinese herbal medicine on dyslipidemia: progress and perspective. Evid Based Complement Alternat Med 2014;2014:163036.
|
18 |
Reiner Z. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol 2017 Jul;14(7):401-11.
DOI
|
19 |
Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013;108(9):1400-15.
DOI
|
20 |
Mata P, Alonso R, Ruiz-Garcia A, Diaz-Diaz JL, Gonzalez N, Gijon-Conde T, et al. Familial combined hyperlipidemia: consensus document. Semergen 2014 Oct;40(7):374-80.
DOI
|
21 |
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative metaanalysis of randomised statin trials. Lancet 2010;375(9716):735-42.
DOI
|
22 |
Cholesterol Treatment Trialists' (CTT) Collaborators, Mihay-lova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380(9841):581-90.
DOI
|
23 |
Thompson PD, Panza G, Zaleski A, Taylor B. Statin-Associated Side Effects. J Am Coll Cardiol 2016 May 24;67(20):2395-410.
|
24 |
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg -Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007 Jul 18;298(3):299-308.
DOI
|
25 |
Liu C, Huang Y. Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action. Front Pharmacol 2016 Dec 1;7:469.
|
26 |
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 Jun;18(6):499-502.
DOI
|
27 |
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298(3):309-16.
DOI
|
28 |
Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011;123(20):2292-333.
DOI
|